US appeal in high-stakes Gilead patent case garners support from patient advocates esagonowsky Wed, 05/31/2023 – 15:32 More: US appeal in high-stakes Gilead patent case garners support from patient advocates Source: fierce
read moreFDA warns patients about compounded versions of Novo Nordisk’s Ozempic, Wegovy kdunleavy Wed, 05/31/2023 – 13:02 More: FDA warns patients about compounded versions of Novo Nordisk's Ozempic, Wegovy Source: fierce
read moreFDA can’t solve drug shortages on its own, agency’s oncology chief says zbecker Wed, 05/31/2023 – 10:34 More: FDA can't solve drug shortages on its own, agency's oncology chief says Source: fierce
read moreNICE gives thumbs-up to Pfizer’s migraine drug—but with lots of restrictions kdunleavy Wed, 05/31/2023 – 09:43 More: NICE gives thumbs-up to Pfizer's migraine drug—but with lots of restrictions Source: fierce
read moreAbbVie’s Rinvoq passes midstage test in systemic lupus erythematosus, heads into phase 3 esagonowsky Wed, 05/31/2023 – 09:39 More: AbbVie's Rinvoq passes midstage test in systemic lupus erythematosus, heads into phase 3 Source: fierce
read moreThe neurological disease affects approximately 2.8 million people worldwide More: Sanofi announces positive data for frexalimab in relapsing MS Source: News
read more© 1994 - 2025 B.M. Pharmaceuticals